Journal of Clinical and Diagnostic Research [serial online] 2018 April [cited: 2018 Apr 11 ]; 12:SD03-SD04. Available from http://jcdr.net/back_issues.asp?issn=0973-709x&year=2018&month=April&volume=12&issue=4&page=SD03-SD04&id=11370 DOI: 10.7860/JCDR/2018/32696.11370
Autoimmune Haemolytic Anaemia: An Unusual Manifestation of Kawasaki Disease Aashish Gupta, Rahi Raza, Ayush Manchanda, Jacob Puliyel
1. Resident, Department of Paediatrics, St Stephens Hospital, Delhi, India. 2. Resident, Department of Paediatrics, St Stephens Hospital, Delhi, India. 3. Consultant, Department of Paediatrics, St Stephens Hospital, Delhi, India. 4. Head of Department, Department of Paediatrics, St Stephens Hospital, Delhi, India.
Correspondence Address :
Dr. Jacob Puliyel,
Head of Department, Department of Paediatrics, St Stephens Hospital, Delhi-110054, India.
Intravenous Immunoglobulin (IVIg) can cause Autoimmune Haemolytic Anaemia (AIHA) in some patients. There are many reports of AIHA developing in children with Kawasaki Disease (KD) after they were treated with IVIg. However, AIHA is seldom reported at the onset of KD, prior to the treatment with IVIg. Here, we report a case of a 10-month-old infant, who developed AIHA alongside the manifestations of KD. Treatment with IVIg resulted in the resolution of symptoms of both KD and AIHA. We also present a review of the literature on similar findings. This suggests that AIHA may be an uncommon manifestation of KD; or that KD and AIHA may both be stimulated, in susceptible persons, by some common agent.
CASE REPORT A 10-month-old infant (with no significant past medical history) presented to the Department of Paediatrics with fever, diarrhoea and vomiting from past two days. He was pale, had an erythematous maculopapular rash all over the body, nonpurulent conjunctivitis, oedema of hands and feet; and dry, cracked and bleeding lips. Blood reports showed leucocytosis (16100/µL) and severe anaemia (Haemoglobin (Hb) 6.1 gm/dL). The initial laboratory reports are presented in the [Table/Fig-1]. The provisional diagnosis at admission was rendered as acute gastroenteritis, malnutrition with severe anaemia and possible sepsis. Empirically, he was started on intravenous ceftriaxone (a dose of 75 mg/kg/day). On the second day of admission, his Hb had fallen to 4.8 gm%. A blood transfusion was planned; however, his blood would not cross-matching with the blood available in the blood bank. Direct and indirect Coombs test were positive (clumping of RBCs was seen). Also, hot and cold auto antibodies (IgG and IgM respectively) were detected in the blood sample, suggestive of AIHA. On the third day of admission, IVIg 1 gm/kg/ day for two days and intravenous dexamethasone at 0.2 mg/kg every eight hours, were started for AIHA. Two discrete lymph nodes of 1.5 cm were noticed in the occipital region and post auricular region on Day four of admission, which were not present on initial presentation. He became afebrile within 48 hours of starting the IVIg infusion and steroids. His Hb went up to 5.6 gm/dL by Day five of admission. An echocardiogram was done on Day six, which revealed dilatation of right coronary artery (diameter of 2.3 mm, Z score of 2.7). The patient met the criteria for KD devised by the American Heart Association . Aspirin was then started at 3 mg/kg/day. Platelet count was found to be 560×103/µL on Day eight of admission. The general condition of child improved and he was discharged from the hospital after eight days of admission, on aspirin at 3 mg/kg/day advised for six weeks. A repeat echocardiography remained pending for the present case. A long term follow up was planned with regular echocardiography; however, the patient was lost to follow up.
DISCUSSION The IVIg is used in the treatment of both KD and AIHA. However, it can also cause AIHA . The AIHA in KD after infusion of immunoglobins was reported by Tocan V et al., . The AIHA seen before IVIg infusion in KD is rare. We performed a systematic search of the literature looking at ‘Autoimmune Haemolytic Disease’ in ‘KD’ before IVIg administration. A search of PubMed (on December 7, 2017) for these keywords yielded 17 reports, out of which seven did not pertain to cases of KD and AIHA, whereas 10 were found relevant. Out of these, four pertained to AIHA prior to the administration of IVIg for KD [4-7]. Hand searching through the references of these papers yielded one more case reported in a journal not indexed with PubMed . The previously reported cases have been tabulated in [Table/ Fig-2]. Two studies that were found were not in English language [7,8]. This is arguably the sixth case report of AIHA as onset of KD. It indicates that AIHA could be a rare manifestation of KD. The aetiology of KD is not known but it is believed that to be an autoimmune phenomenon provoked by bacterial, viral, mycoplasma, or non-living allergen [9,10].
CONCLUSION One can speculate that both KD and AIHA are stimulated in susceptible persons by some common agent or maybe AIHA is a rare manifestation of KD. The exact aetiology of KD is not known even though there are many known causes for AIHA. The association between KD and AIHA may help, in the future, to elucidate the aetiology of KD.
REFERENCES McCrindle BW, Rowley AH, Newburger JW,  Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association Circulation. 2017;135(17):e927-99. Thakkar D, Radhakrishnan N, Pruthi PK, Sachdeva A. Kawasaki disease with  autoimmune haemolytic anaemia. Indian Pediatr. 2015;52:245-46.  Jiang J, Song XW, Zhang QY. A case of Kawasaki disease with autoimmune haemolytic anaemia. Zhonghua Er Ke Za Zhi. 2016;54(6):465-66.
Bunin NJ, Carev JL, Sullivan DB. Autoimmunehaemolytic anaemia in association  with Kawasaki disease. Am J Pediatr Hematol Oncol. 1986;8(4):351-53. Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse  effects and safe administration. Clin Rev Allergy Immunol. 2005;29(3):173-84. Tocan V, Inaba A, Kurano T, Sonoda M, Soebijanto K, Nakayama H. Severe  haemolytic anaemia following intravenous immunoglobulin in an infant with kawasaki disease. J Pediatr Hematol Oncol. 2017;39(2):e100-e102. Cataldo F, Violante M, Bellia L, Gueci G, Maltese I, Albeggiani A. Autoimmune  haemolytic anaemia in the course of Kawasaki disease. A case presentation. Minerva Pediatr. 1991;43(10):661-64.  Hong JH, Kwon YJ, Lee KY, Kil HR, Lee HS, Lee MH, et al. A Case of Atypical Kawasaki Disease with Autoimmune Haemolytic Anaemia. J Korean Pediatr Cardiol Soc. 2005;9(2):400-04. Available at https://koreamed.org/SearchBasic.php?RID= 2054JKPCS%2F2005.9.2.400&DT=1&QY. Accessed on 14 February 2017 Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen  involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol. 1995;155(10):5018-21. Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, et  al. Prevalence of super-antigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002;140(6):742-46.